Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-SARS-Cov-2 antibodies derived from CR3022

Anti-SARS-Cov-2 antibodies derived from CR3022

US Patent 11034762 · Granted Jun 15, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System for generating immunoglobulin scaffolds for grafting non-human CDR amino 2025
Anti-phosphocholine antibodies and methods of use thereof2025
Epitope focusing by variable effective antigen surface concentration2024
Compositions and methods for the depletion of CD117+ cells2024
MAdCAM targeted immunotolerance2023
Method for mass humanization of rabbit antibodies2023
Epitope focusing by variable effective antigen surface concentration2023
GPCR binding proteins and synthesis thereof2022
Anti-PD-1 antibodies and methods of use thereof2022
Method for mass humanization of non-human antibodies2021
Anti-SARS-Cov-2 antibodies derived from 6nb62021
Anti-SARS-Cov-2 antibodies derived from 6nb62021